Evidence map›Paper›PMID 37147098›Full record

ArticleBMJ open2023

Point-of-care measurement of C-reactive protein promotes de-escalation of treatment decisions and strengthens the perceived clinical confidence of physicians in out-of-hours outpatient emergency medical services.

Anni Matthes, Florian Wolf, Elmar Wilde, Jutta Bleidorn, Robby Markwart

Abstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anni MatthesInstitute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Florian WolfInstitute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Elmar WildePractice Network HilMed Hildesheim, Hildesheim, Germany.
Jutta BleidornInstitute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Robby MarkwartInstitute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany robby.markwart@med.uni-jena.de.ORCID 0000-0003-0338-3433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesOut-of-hours outpatient emergency medical services (OEMS) provide healthcare for patients with non-life-threatening conditions in need for urgent care when outpatient practices are closed. We studied the use of point-of-care-testing of C-reactive protein (CRP-POCT) at OEMS.

designCross-sectional questionnaire-based survey.

settingSingle centre OEMS practice in Hildesheim, Germany (October 2021 to March 2022).

participantsOEMS physicians answering a questionnaire immediately after performing CRP-POCTs (CUBE-S Analyzer, Hitado) on any patients. PRIMARY AND SECONDARY OUTCOMES: Impact of CRP-POCTs on clinical decision-making and perceived usefulness.

resultsIn the 6-month study period, 114 valid CRP-POCTs were performed in the OEMS practice by 18 physicians and the questionnaire was answered in 112 cases (response rate: 98.2%). CRP-POCTs were used in the diagnosis of inflammatory diseases of the gastrointestinal tract (60.0%), respiratory tract infections (17.0%), urinary tract infections (9.0%) and other non-gastrointestinal/non-specified infections (11.0%). The use of a CRP-POCT resulted in a change of the physicians' clinical decision in 83.3% of the cases. Specifically, in 13.6% and 35.1% of the cases, rapid CRP measurements led to decision changes in the (1) initiation of antimicrobial therapy and (2) other drug treatment, respectively. Notably, in 60% of all cases, the use of a CRP-POCT reportedly changed the decision on hospitalisation/non-hospitalisation of OEMS patients. In respect of antimicrobial therapy and hospitalisation, these decision changes primarily (≥73%) promoted 'step-down' decisions, that is, no antibiotic therapy and no hospital admission. In the great majority of CRP-POCT applications (≥95%), OEMS physicians reported that rapid CRP measurements increased the confidence in their diagnostic and therapeutic decision. In almost all cases (97%), physicians rated the CRP-POCT use as useful in the treatment situation.

conclusionQuantitative CRP-POCT promotes step-down clinical decisions and strengthens the clinical confidence of physicians in out-of-hours OEMS.

Indexed as

After-Hours CareC-Reactive ProteinPoint-of-Care TestingCross-Sectional StudiesHumansOutpatientsPoint-of-Care SystemsC-Reactive ProteinACCIDENT & EMERGENCY MEDICINEDiagnostic microbiologyGENERAL MEDICINE (see Internal Medicine)

Identifiers

PMID37147098
PMCPMC10163444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.